Epigenomics' IPO

Epigenomics raised a round of funding on July 05, 2004. Investors include Public.

Epigenomics is a molecular diagnostics company focusing on blood-based detection of cancers using its proprietary DNA methylation technology. The company develops and commercializes blood-based diagno…

Articles about Epigenomics' IPO: